Bio-Rad Labs Buys AbD Serotec for €53M
Posted on January 10, 2013 at 09:07 AM EST
Bio-Rad Laboratories, Inc. (NYSE: BIO ) and (NYSE: BIO.B), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced that it has purchased AbD Serotec, a division of MorphoSys AG, for approximately 53 million euros in cash. AbD Serotec is one of the world's leading antibody manufacturers offering over